data_1l5d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1l5d _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.533 0.206 . . . . 8.8000000000000007 110.533 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -46.67 159.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.852 -0.425 . . . . 7.5199999999999996 109.852 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.558 ' HG ' ' HD3' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -68.11 153.82 42.95 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 120.873 0.368 . . . . 5.3099999999999996 110.439 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -77.66 -71.15 0.43 Allowed 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.763 -0.653 . . . . 5.9199999999999999 110.193 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.783 HD11 ' H ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -141.42 -137.09 0.11 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.729 -1.123 . . . . 8.6600000000000001 111.073 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.52 -30.68 29.64 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 112.13 0.418 . . . . 9.5 112.13 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.783 ' H ' HD11 ' A' ' 5' ' ' LEU . 27.3 m -108.88 84.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.657 0.741 . . . . 9.3499999999999996 111.146 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.558 ' HD3' ' HG ' ' A' ' 3' ' ' LEU . 4.8 mtt180 -84.49 -161.63 0.58 Allowed 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.37 -1.286 . . . . 7.7699999999999996 112.336 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.4 m 47.15 79.85 0.06 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.65 -0.705 . . . . 5.4299999999999997 110.571 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.418 ' CA ' ' HB2' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -54.56 178.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.632 -0.713 . . . . 3.6600000000000001 111.765 -178.589 -123.981 20.098 54.728 105.72 2.035 104.432 77.079 17.543 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' CD2' ' HG3' ' A' ' 46' ' ' GLU . 1.5 mp -68.91 112.97 13.15 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.068 -0.969 . . . . 3.9199999999999999 111.542 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.2 Cg_exo -54.4 -174.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.63 1.553 . . . . 1.9299999999999999 111.976 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -156.12 179.11 9.54 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.681 -0.691 . . . . 1.25 110.472 179.959 -141.945 146.806 104.934 102.503 2.025 103.367 -154.068 -108.214 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.632 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . 61.41 -136.67 47.48 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 119.964 -1.113 . . . . 1.28 113.394 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -89.46 108.87 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 124.14 3.226 . . . . 1.78 113.181 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.85 -70.31 2.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 1.8600000000000001 112.352 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.498 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.24 34.37 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.052 0 CA-C-O 121.53 0.517 . . . . 1.7 112.156 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -36.42 74.09 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.81 -0.695 . . . . 2.3900000000000001 110.383 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -105.77 -171.94 23.61 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 114.612 -1.176 . . . . 1.24 112.255 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.51 -178.97 5.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.86 -0.422 . . . . 3.9399999999999999 109.86 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.0 m -78.1 160.96 27.75 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.164 -0.471 . . . . 1.8 110.155 178.377 -67.484 -106.764 134.359 103.37 2.027 103.6 64.147 -142.177 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' HB2' HG23 ' A' ' 26' ' ' ILE . 17.1 m-85 -140.72 -34.06 0.52 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.999 -0.68 . . . . 2.5800000000000001 112.461 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.539 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -168.0 -105.71 0.19 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.48 -0.867 . . . . 2.1299999999999999 113.665 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 46.4 Cg_endo -99.72 107.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.334 2.689 . . . . 2.3999999999999999 113.513 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.67 32.3 2.49 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.716 -0.476 . . . . 2.1000000000000001 109.716 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.671 HD12 HG12 ' A' ' 36' ' ' VAL . 2.4 tt -121.18 160.61 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 114.008 1.114 . . . . 1.73 114.008 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -152.95 144.3 23.26 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.668 -1.605 . . . . 1.27 109.674 -179.182 -108.214 -154.068 104.934 103.367 2.025 102.503 146.806 -141.945 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -144.58 101.39 3.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 119.352 -0.356 . . . . 1.25 111.73 -178.276 -120.929 41.462 -113.474 105.017 2.023 103.18 106.77 -148.164 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.887 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -84.68 114.06 3.87 Favored Glycine 0 N--CA 1.404 -3.434 0 C-N-CA 119.18 -1.486 . . . . 1.02 109.778 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 43.4 t0 -54.37 -61.12 2.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.622 -1.251 . . . . 1.97 107.622 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -83.54 26.89 0.64 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.068 -1.086 . . . . 2.46 108.068 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.887 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -157.06 34.06 0.29 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.041 0.756 . . . . 1.7 113.041 -175.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.607 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . 45.01 -165.71 0.05 OUTLIER Glycine 0 C--O 1.224 -0.488 0 N-CA-C 114.59 0.596 . . . . 1.3200000000000001 114.59 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 27' ' ' CYS . 1.5 t -129.98 141.72 50.72 Favored 'General case' 0 CA--C 1.523 -0.063 0 N-CA-C 113.404 0.89 . . . . 1.1799999999999999 113.404 -177.496 -148.164 106.77 -113.474 103.18 2.023 105.017 41.462 -120.929 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -135.25 121.56 20.34 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.926 -1.034 . . . . 1.4099999999999999 110.937 178.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.671 HG12 HD12 ' A' ' 26' ' ' ILE . 3.0 t -99.24 107.53 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.254 -0.578 . . . . 1.95 109.908 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.34 28.45 59.14 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.425 -0.893 . . . . 1.79 112.107 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -93.5 -174.05 3.38 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 122.402 0.281 . . . . 2.21 110.458 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -60.32 -48.57 81.18 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.123 0.487 . . . . 1.8999999999999999 110.501 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -78.46 7.64 6.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 1.97 111.417 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.79 -21.28 12.15 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.035 0.383 . . . . 1.55 112.035 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.741 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -55.47 -13.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.087 0.773 . . . . 1.8700000000000001 113.087 -178.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.665 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -54.11 -22.83 11.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.906 0.384 . . . . 2.75 111.223 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.6 -8.05 59.48 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.618 0.599 . . . . 1.8999999999999999 112.618 -179.524 -142.177 64.147 134.359 103.6 2.027 103.37 -106.764 -67.484 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -59.22 -25.79 64.31 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.711 -0.848 . . . . 2.7799999999999998 108.711 177.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.665 ' HG2' ' O ' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -82.02 -12.37 58.34 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.849 -1.069 . . . . 3.7000000000000002 110.422 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -80.74 -7.06 59.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.043 -0.526 . . . . 3.3799999999999999 110.441 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -73.13 -18.65 61.26 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.177 -0.465 . . . . 4.5 110.884 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -95.17 -34.67 12.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.01 0.433 . . . . 6.7999999999999998 111.521 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -116.88 95.37 46.57 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.74 -0.663 . . . . 7.3700000000000001 111.837 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -71.57 -23.27 23.43 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.565 2.843 . . . . 7.9500000000000002 113.594 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 3.9 m -28.34 107.07 0.22 Allowed Pre-proline 0 C--N 1.303 -1.452 0 CA-C-N 113.34 -1.755 . . . . 7.2400000000000002 112.589 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 52' ' ' SER . 15.9 Cg_endo -57.57 105.09 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.029 1.819 . . . . 7.3899999999999997 109.819 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.446 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -108.09 147.61 30.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.81 -0.632 . . . . 4.6100000000000003 112.023 -177.603 17.543 77.079 54.728 104.432 2.035 105.72 20.098 -123.981 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 54' ' ' CYS . 2.4 tt0 -24.92 137.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.214 -0.903 . . . . 5.6100000000000003 111.606 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 m -124.91 178.71 5.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.075 -0.512 . . . . 4.9900000000000002 110.042 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.453 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -129.55 43.41 1.31 Allowed Glycine 0 CA--C 1.492 -1.403 0 C-N-CA 119.164 -1.493 . . . . 3.0600000000000001 110.614 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.499 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 5.2 mm100 -96.7 82.51 3.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 113.156 0.799 . . . . 4.5499999999999998 113.156 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.455 ' CG ' ' HB3' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -76.75 108.64 6.88 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 109.022 -0.733 . . . . 3.4900000000000002 109.022 176.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.657 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 94.4 Cg_exo -39.78 156.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.11 2.54 . . . . 1.79 115.684 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -161.83 155.26 21.1 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.279 -1.328 . . . . 1.3799999999999999 110.2 178.02 19.286 94.843 110.249 105.606 2.034 103.023 90.23 -167.815 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.24 6.89 12.63 Favored Glycine 0 N--CA 1.44 -1.093 0 CA-C-N 115.008 -0.996 . . . . 1.76 113.564 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.1 t -93.31 41.72 1.09 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 117.386 0.593 . . . . 1.6599999999999999 111.147 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.43 44.41 96.8 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.872 -0.604 . . . . 1.8300000000000001 114.302 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.476 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 157.52 -150.74 21.87 Favored Glycine 0 CA--C 1.502 -0.732 0 C-N-CA 120.864 -0.684 . . . . 1.48 114.33 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.657 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 5.3 mmt180 -122.34 155.46 35.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.185 -0.508 . . . . 3.3999999999999999 110.151 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 17.6 t -63.31 160.14 16.51 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.346 -0.613 . . . . 1.1699999999999999 109.346 178.541 -167.669 134.57 -135.554 104.103 2.032 102.625 -163.509 -103.311 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.686 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -154.16 -99.23 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.798 -0.637 . . . . 1.3799999999999999 112.265 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.828 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -73.13 -169.92 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.624 1.17 . . . . 1.3899999999999999 112.792 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.796 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -39.31 75.59 0.0 OUTLIER 'General case' 0 C--N 1.366 1.29 0 N-CA-C 109.069 -0.715 . . . . 1.6799999999999999 109.069 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 1.011 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 57.33 79.52 0.1 OUTLIER Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 118.276 -1.916 . . . . 1.1499999999999999 108.678 -175.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.686 ' O ' ' N ' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -145.4 120.43 3.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.846 -0.798 . . . . 1.48 108.846 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.1 t -99.95 102.09 13.37 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.837 -1.542 . . . . 0.98999999999999999 106.837 179.952 -167.815 90.23 110.249 103.023 2.034 105.606 94.843 19.286 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.1 t -88.93 153.95 20.62 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 113.424 0.898 . . . . 1.2 113.424 -175.777 -151.655 108.037 -75.627 103.919 2.028 104.69 -33.734 -45.0 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.468 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -121.65 -179.16 0.7 Allowed Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 113.714 -1.585 . . . . 1.6799999999999999 110.671 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.468 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -72.75 -10.57 25.14 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.857 2.371 . . . . 2.2000000000000002 112.139 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.7 -32.33 7.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 2.6699999999999999 111.256 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.87 170.07 38.22 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.804 -0.712 . . . . 1.6200000000000001 112.756 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.624 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 10.4 m -98.56 162.36 13.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.099 0.407 . . . . 1.3500000000000001 112.099 -179.932 -45.0 -33.734 -75.627 104.69 2.028 103.919 108.037 -151.655 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.45 145.82 24.8 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.726 -0.67 . . . . 1.8899999999999999 109.93 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.552 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -61.4 109.62 1.21 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 120.983 0.42 . . . . 2.3799999999999999 111.437 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.779 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 26.9 p-10 -91.08 118.01 68.26 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.806 -0.634 . . . . 2.1800000000000002 111.459 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.571 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 35.9 Cg_exo -61.56 -15.87 44.31 Favored 'Trans proline' 0 CA--C 1.509 -0.763 0 C-N-CA 124.786 3.657 . . . . 1.54 110.797 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.21 -12.53 59.63 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.481 -1.69 . . . . 1.6000000000000001 112.776 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 1.011 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -123.88 -23.06 4.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 119.27 3.063 . . . . 1.25 119.27 -174.796 -103.311 -163.509 -135.554 102.625 2.032 104.103 134.57 -167.669 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.82 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.7 t70 167.2 -29.14 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.125 0 N-CA-C 119.55 3.167 . . . . 1.99 119.55 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.796 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.2 Cg_endo -102.09 -73.49 0.0 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.255 0 C-N-CA 123.447 2.765 . . . . 1.79 111.015 -175.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.4 ' H ' ' HD2' ' A' ' 87' ' ' PRO . 5.1 tt0 -71.07 -6.46 39.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.72 -1.582 . . . . 2.3999999999999999 106.997 176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 83' ' ' PRO . . . -76.76 -158.01 0.1 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 113.416 -1.72 . . . . 1.8999999999999999 112.526 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.69 -173.18 0.31 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.818 -1.083 . . . . 2.3700000000000001 108.536 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -73.08 62.03 0.62 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.96 -1.496 . . . . 5.6100000000000003 106.96 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.585 ' OG ' ' HA ' ' A' ' 86' ' ' ASP . 1.8 t . . . . . 0 C--O 1.25 1.119 0 CA-C-N 114.46 -1.246 . . . . 2.71 111.15 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.533 0.206 . . . . 8.4900000000000002 110.533 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -46.67 159.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.852 -0.425 . . . . 7.1900000000000004 109.852 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.711 HD12 ' HG2' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -68.11 153.82 42.95 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 120.873 0.368 . . . . 4.8600000000000003 110.439 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -77.66 -71.15 0.43 Allowed 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.763 -0.653 . . . . 5.9199999999999999 110.193 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.94 HD13 ' H ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -141.42 -137.09 0.11 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.729 -1.123 . . . . 8.25 111.073 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.52 -30.68 29.64 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 112.13 0.418 . . . . 9.5 112.13 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.94 ' H ' HD13 ' A' ' 5' ' ' LEU . 27.3 m -108.88 84.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.657 0.741 . . . . 8.9700000000000006 111.146 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.711 ' HG2' HD12 ' A' ' 3' ' ' LEU . 4.8 mtt180 -84.49 -161.63 0.58 Allowed 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.37 -1.286 . . . . 7.0700000000000003 112.336 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.4 m 47.15 79.85 0.06 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.65 -0.705 . . . . 5.0199999999999996 110.571 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.41 ' CA ' ' HB2' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -54.56 178.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.632 -0.713 . . . . 3.6600000000000001 111.765 -178.589 -123.981 20.098 54.728 105.72 2.035 104.432 77.079 17.543 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.013 HD23 ' HG3' ' A' ' 46' ' ' GLU . 1.5 mp -68.91 112.97 13.15 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.068 -0.969 . . . . 3.3599999999999999 111.542 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.2 Cg_exo -54.4 -174.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.63 1.553 . . . . 1.77 111.976 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -156.12 179.11 9.54 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.681 -0.691 . . . . 1.21 110.472 179.959 -141.945 146.806 104.934 102.503 2.025 103.367 -154.068 -108.214 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.41 -136.67 47.48 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 119.964 -1.113 . . . . 1.28 113.394 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -89.46 108.87 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 124.14 3.226 . . . . 1.71 113.181 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.85 -70.31 2.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 1.76 112.352 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.24 34.37 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.052 0 CA-C-O 121.53 0.517 . . . . 1.6299999999999999 112.156 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -70.39 -36.42 74.09 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.81 -0.695 . . . . 2.0699999999999998 110.383 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -105.77 -171.94 23.61 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 114.612 -1.176 . . . . 1.24 112.255 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.485 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.51 -178.97 5.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.86 -0.422 . . . . 3.1800000000000002 109.86 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.0 m -78.1 160.96 27.75 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.164 -0.471 . . . . 1.5900000000000001 110.155 178.377 -67.484 -106.764 134.359 103.37 2.027 103.6 64.147 -142.177 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.572 ' HB2' HG23 ' A' ' 26' ' ' ILE . 17.1 m-85 -140.72 -34.06 0.52 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.999 -0.68 . . . . 2.1000000000000001 112.461 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.584 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -168.0 -105.71 0.19 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.48 -0.867 . . . . 2.1299999999999999 113.665 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 46.4 Cg_endo -99.72 107.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.334 2.689 . . . . 2.25 113.513 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.67 32.3 2.49 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.716 -0.476 . . . . 1.9399999999999999 109.716 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 23' ' ' GLY . 2.4 tt -121.18 160.61 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 114.008 1.114 . . . . 1.51 114.008 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -152.95 144.3 23.26 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.668 -1.605 . . . . 1.1699999999999999 109.674 -179.182 -108.214 -154.068 104.934 103.367 2.025 102.503 146.806 -141.945 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -144.58 101.39 3.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 119.352 -0.356 . . . . 1.25 111.73 -178.276 -120.929 41.462 -113.474 105.017 2.023 103.18 106.77 -148.164 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.92 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -84.68 114.06 3.87 Favored Glycine 0 N--CA 1.404 -3.434 0 C-N-CA 119.18 -1.486 . . . . 1.02 109.778 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 43.4 t0 -54.37 -61.12 2.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.622 -1.251 . . . . 1.97 107.622 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -83.54 26.89 0.64 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.068 -1.086 . . . . 2.46 108.068 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.92 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -157.06 34.06 0.29 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.041 0.756 . . . . 1.3100000000000001 113.041 -175.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.713 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 45.01 -165.71 0.05 OUTLIER Glycine 0 C--O 1.224 -0.488 0 N-CA-C 114.59 0.596 . . . . 1.1299999999999999 114.59 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 27' ' ' CYS . 1.5 t -129.98 141.72 50.72 Favored 'General case' 0 CA--C 1.523 -0.063 0 N-CA-C 113.404 0.89 . . . . 1.1799999999999999 113.404 -177.496 -148.164 106.77 -113.474 103.18 2.023 105.017 41.462 -120.929 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.649 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -135.25 121.56 20.34 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.926 -1.034 . . . . 1.25 110.937 178.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.476 HG13 HG13 ' A' ' 26' ' ' ILE . 3.0 t -99.24 107.53 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.254 -0.578 . . . . 1.6799999999999999 109.908 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.34 28.45 59.14 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.425 -0.893 . . . . 1.6499999999999999 112.107 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -93.5 -174.05 3.38 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 122.402 0.281 . . . . 1.8400000000000001 110.458 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.548 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.32 -48.57 81.18 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.123 0.487 . . . . 1.5 110.501 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.412 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.2 mp0 -78.46 7.64 6.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 1.97 111.417 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -110.79 -21.28 12.15 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.035 0.383 . . . . 1.1000000000000001 112.035 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -55.47 -13.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.087 0.773 . . . . 1.45 113.087 -178.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.696 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -54.11 -22.83 11.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.906 0.384 . . . . 2.3700000000000001 111.223 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.6 -8.05 59.48 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.618 0.599 . . . . 1.8999999999999999 112.618 -179.524 -142.177 64.147 134.359 103.6 2.027 103.37 -106.764 -67.484 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 1.5 mt-30 -59.22 -25.79 64.31 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.711 -0.848 . . . . 2.7799999999999998 108.711 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.013 ' HG3' HD23 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -82.02 -12.37 58.34 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.849 -1.069 . . . . 3.7000000000000002 110.422 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -80.74 -7.06 59.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.043 -0.526 . . . . 3.3799999999999999 110.441 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -73.13 -18.65 61.26 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.177 -0.465 . . . . 4.4100000000000001 110.884 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -95.17 -34.67 12.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.01 0.433 . . . . 6.5899999999999999 111.521 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 50' ' ' LEU . 2.1 tp -116.88 95.37 46.57 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.74 -0.663 . . . . 6.9800000000000004 111.837 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -71.57 -23.27 23.43 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.565 2.843 . . . . 7.2199999999999998 113.594 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.46 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 3.9 m -28.34 107.07 0.22 Allowed Pre-proline 0 C--N 1.303 -1.452 0 CA-C-N 113.34 -1.755 . . . . 7.0 112.589 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 52' ' ' SER . 15.9 Cg_endo -57.57 105.09 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.029 1.819 . . . . 6.71 109.819 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.446 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -108.09 147.61 30.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.81 -0.632 . . . . 4.3300000000000001 112.023 -177.603 17.543 77.079 54.728 104.432 2.035 105.72 20.098 -123.981 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 54' ' ' CYS . 2.4 tt0 -24.92 137.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.214 -0.903 . . . . 4.9299999999999997 111.606 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 m -124.91 178.71 5.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.075 -0.512 . . . . 4.6799999999999997 110.042 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.447 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -129.55 43.41 1.31 Allowed Glycine 0 CA--C 1.492 -1.403 0 C-N-CA 119.164 -1.493 . . . . 2.6299999999999999 110.614 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.514 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 5.2 mm100 -96.7 82.51 3.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 113.156 0.799 . . . . 4.2699999999999996 113.156 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.506 ' H ' ' HG2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -76.75 108.64 6.88 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 109.022 -0.733 . . . . 3.0800000000000001 109.022 176.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.574 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 94.4 Cg_exo -39.78 156.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.11 2.54 . . . . 1.6399999999999999 115.684 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -161.83 155.26 21.1 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.279 -1.328 . . . . 1.3799999999999999 110.2 178.02 19.286 94.843 110.249 105.606 2.034 103.023 90.23 -167.815 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.24 6.89 12.63 Favored Glycine 0 N--CA 1.44 -1.093 0 CA-C-N 115.008 -0.996 . . . . 1.76 113.564 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.1 t -93.31 41.72 1.09 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 117.386 0.593 . . . . 1.47 111.147 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.43 44.41 96.8 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.872 -0.604 . . . . 1.7 114.302 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.485 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 157.52 -150.74 21.87 Favored Glycine 0 CA--C 1.502 -0.732 0 C-N-CA 120.864 -0.684 . . . . 1.45 114.33 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 5.3 mmt180 -122.34 155.46 35.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.185 -0.508 . . . . 2.77 110.151 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 17.6 t -63.31 160.14 16.51 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.346 -0.613 . . . . 1.1699999999999999 109.346 178.541 -167.669 134.57 -135.554 104.103 2.032 102.625 -163.509 -103.311 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.686 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -154.16 -99.23 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.798 -0.637 . . . . 1.25 112.265 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.828 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -73.13 -169.92 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.624 1.17 . . . . 0.89000000000000001 112.792 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.82 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -39.31 75.59 0.0 OUTLIER 'General case' 0 C--N 1.366 1.29 0 N-CA-C 109.069 -0.715 . . . . 1.29 109.069 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.037 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 57.33 79.52 0.1 OUTLIER Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 118.276 -1.916 . . . . 1.0900000000000001 108.678 -175.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.697 HD13 ' C ' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -145.4 120.43 3.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.846 -0.798 . . . . 0.98999999999999999 108.846 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.1 t -99.95 102.09 13.37 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.837 -1.542 . . . . 0.98999999999999999 106.837 179.952 -167.815 90.23 110.249 103.023 2.034 105.606 94.843 19.286 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.1 t -88.93 153.95 20.62 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 113.424 0.898 . . . . 1.2 113.424 -175.777 -151.655 108.037 -75.627 103.919 2.028 104.69 -33.734 -45.0 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.483 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -121.65 -179.16 0.7 Allowed Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 113.714 -1.585 . . . . 1.5700000000000001 110.671 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -72.75 -10.57 25.14 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.857 2.371 . . . . 2.1000000000000001 112.139 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.7 -32.33 7.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 2.6699999999999999 111.256 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.87 170.07 38.22 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.804 -0.712 . . . . 1.6200000000000001 112.756 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.632 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 10.4 m -98.56 162.36 13.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.099 0.407 . . . . 1.3500000000000001 112.099 -179.932 -45.0 -33.734 -75.627 104.69 2.028 103.919 108.037 -151.655 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.697 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.45 145.82 24.8 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.726 -0.67 . . . . 1.8899999999999999 109.93 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.475 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -61.4 109.62 1.21 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 120.983 0.42 . . . . 2.3799999999999999 111.437 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.779 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 26.9 p-10 -91.08 118.01 68.26 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.806 -0.634 . . . . 2.1800000000000002 111.459 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.575 ' HA ' ' N ' ' A' ' 89' ' ' ALA . 35.9 Cg_exo -61.56 -15.87 44.31 Favored 'Trans proline' 0 CA--C 1.509 -0.763 0 C-N-CA 124.786 3.657 . . . . 1.4199999999999999 110.797 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.21 -12.53 59.63 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.481 -1.69 . . . . 1.26 112.776 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 1.037 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -123.88 -23.06 4.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 119.27 3.063 . . . . 1.25 119.27 -174.796 -103.311 -163.509 -135.554 102.625 2.032 104.103 134.57 -167.669 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.841 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.7 t70 167.2 -29.14 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.125 0 N-CA-C 119.55 3.167 . . . . 1.99 119.55 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.82 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.2 Cg_endo -102.09 -73.49 0.0 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.255 0 C-N-CA 123.447 2.765 . . . . 1.79 111.015 -175.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' OE1' ' HG3' ' A' ' 81' ' ' GLU . 5.1 tt0 -71.07 -6.46 39.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.72 -1.582 . . . . 2.3999999999999999 106.997 176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.575 ' N ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.76 -158.01 0.1 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 113.416 -1.72 . . . . 1.8999999999999999 112.526 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.69 -173.18 0.31 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.818 -1.083 . . . . 2.0899999999999999 108.536 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -73.08 62.03 0.62 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.96 -1.496 . . . . 4.8200000000000003 106.96 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.473 ' CB ' ' HA ' ' A' ' 86' ' ' ASP . 1.8 t . . . . . 0 C--O 1.25 1.119 0 CA-C-N 114.46 -1.246 . . . . 2.71 111.15 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.533 0.206 . . . . 8.49 110.533 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -46.67 159.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.852 -0.425 . . . . 7.19 109.852 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.711 HD12 ' HG2' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -68.11 153.82 42.95 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 120.873 0.368 . . . . 4.86 110.439 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -77.66 -71.15 0.43 Allowed 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.763 -0.653 . . . . 5.92 110.193 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.94 HD13 ' H ' ' A' ' 7' ' ' VAL . 0.4 OUTLIER -141.42 -137.09 0.11 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.729 -1.123 . . . . 8.25 111.073 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.52 -30.68 29.64 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 112.13 0.418 . . . . 9.5 112.13 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.94 ' H ' HD13 ' A' ' 5' ' ' LEU . 27.3 m -108.88 84.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.657 0.741 . . . . 8.97 111.146 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.711 ' HG2' HD12 ' A' ' 3' ' ' LEU . 4.8 mtt180 -84.49 -161.63 0.58 Allowed 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.37 -1.286 . . . . 7.07 112.336 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.4 m 47.15 79.85 0.06 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.65 -0.705 . . . . 5.02 110.571 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.41 ' CA ' ' HB2' ' A' ' 54' ' ' CYS . 0.0 OUTLIER -54.56 178.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.632 -0.713 . . . . 3.66 111.765 -178.589 -123.981 20.098 54.728 105.72 2.035 104.432 77.079 17.543 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.013 HD23 ' HG3' ' A' ' 46' ' ' GLU . 1.5 mp -68.91 112.97 13.15 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.068 -0.969 . . . . 3.36 111.542 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 32.2 Cg_exo -54.4 -174.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.63 1.553 . . . . 1.77 111.976 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -156.12 179.11 9.54 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.681 -0.691 . . . . 1.21 110.472 179.959 -141.945 146.806 104.934 102.503 2.025 103.367 -154.068 -108.214 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . 61.41 -136.67 47.48 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 119.964 -1.113 . . . . 1.28 113.394 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -89.46 108.87 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 124.14 3.226 . . . . 1.71 113.181 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.85 -70.31 2.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 1.76 112.352 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' CA ' ' HB3' ' A' ' 12' ' ' PRO . . . 177.24 34.37 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.052 0 CA-C-O 121.53 0.517 . . . . 1.63 112.156 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -70.39 -36.42 74.09 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.81 -0.695 . . . . 2.07 110.383 -179.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 12' ' ' PRO . . . -105.77 -171.94 23.61 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 114.612 -1.176 . . . . 1.24 112.255 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.485 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -165.51 -178.97 5.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.86 -0.422 . . . . 3.18 109.86 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.0 m -78.1 160.96 27.75 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.164 -0.471 . . . . 1.59 110.155 178.377 -67.484 -106.764 134.359 103.37 2.027 103.6 64.147 -142.177 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.572 ' HB2' HG23 ' A' ' 26' ' ' ILE . 17.1 m-85 -140.72 -34.06 0.52 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.999 -0.68 . . . . 2.1 112.461 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.584 ' H ' HG22 ' A' ' 26' ' ' ILE . . . -168.0 -105.71 0.19 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.48 -0.867 . . . . 2.13 113.665 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HD3' ' HA3' ' A' ' 23' ' ' GLY . 46.4 Cg_endo -99.72 107.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.334 2.689 . . . . 2.25 113.513 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.67 32.3 2.49 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.716 -0.476 . . . . 1.94 109.716 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 23' ' ' GLY . 2.4 tt -121.18 160.61 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 114.008 1.114 . . . . 1.51 114.008 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -152.95 144.3 23.26 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.668 -1.605 . . . . 1.17 109.674 -179.182 -108.214 -154.068 104.934 103.367 2.025 102.503 146.806 -141.945 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -144.58 101.39 3.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 119.352 -0.356 . . . . 1.25 111.73 -178.276 -120.929 41.462 -113.474 105.017 2.023 103.18 106.77 -148.164 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.92 ' HA3' ' HB3' ' A' ' 32' ' ' LEU . . . -84.68 114.06 3.87 Favored Glycine 0 N--CA 1.404 -3.434 0 C-N-CA 119.18 -1.486 . . . . 1.02 109.778 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 69' ' ' ALA . 43.4 t0 -54.37 -61.12 2.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.622 -1.251 . . . . 1.97 107.622 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -83.54 26.89 0.64 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.068 -1.086 . . . . 2.46 108.068 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.92 ' HB3' ' HA3' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -157.06 34.06 0.29 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 113.041 0.756 . . . . 1.31 113.041 -175.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.713 ' C ' ' HB1' ' A' ' 69' ' ' ALA . . . 45.01 -165.71 0.05 OUTLIER Glycine 0 C--O 1.224 -0.488 0 N-CA-C 114.59 0.596 . . . . 1.13 114.59 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 27' ' ' CYS . 1.5 t -129.98 141.72 50.72 Favored 'General case' 0 CA--C 1.523 -0.063 0 N-CA-C 113.404 0.89 . . . . 1.18 113.404 -177.496 -148.164 106.77 -113.474 103.18 2.023 105.017 41.462 -120.929 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.649 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -135.25 121.56 20.34 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.926 -1.034 . . . . 1.25 110.937 178.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.476 HG13 HG13 ' A' ' 26' ' ' ILE . 3.0 t -99.24 107.53 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.254 -0.578 . . . . 1.68 109.908 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 57.34 28.45 59.14 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.425 -0.893 . . . . 1.65 112.107 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -93.5 -174.05 3.38 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 122.402 0.281 . . . . 1.84 110.458 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.548 ' H ' HG22 ' A' ' 38' ' ' THR . . . -60.32 -48.57 81.18 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.123 0.487 . . . . 1.5 110.501 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.412 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 1.2 mp0 -78.46 7.64 6.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 1.97 111.417 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 35' ' ' PHE . . . -110.79 -21.28 12.15 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.035 0.383 . . . . 1.1 112.035 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.72 ' N ' HD12 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -55.47 -13.83 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.087 0.773 . . . . 1.45 113.087 -178.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.696 ' O ' ' HG2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -54.11 -22.83 11.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.906 0.384 . . . . 2.37 111.223 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.6 -8.05 59.48 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.618 0.599 . . . . 1.9 112.618 -179.524 -142.177 64.147 134.359 103.6 2.027 103.37 -106.764 -67.484 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -59.22 -25.79 64.31 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.711 -0.848 . . . . 2.78 108.711 177.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.013 ' HG3' HD23 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -82.02 -12.37 58.34 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 114.849 -1.069 . . . . 3.7 110.422 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -80.74 -7.06 59.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.043 -0.526 . . . . 3.38 110.441 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -73.13 -18.65 61.26 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.177 -0.465 . . . . 4.41 110.884 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -95.17 -34.67 12.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.01 0.433 . . . . 6.59 111.521 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 50' ' ' LEU . 2.1 tp -116.88 95.37 46.57 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.74 -0.663 . . . . 6.98 111.837 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -71.57 -23.27 23.43 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.565 2.843 . . . . 7.22 113.594 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.46 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 3.9 m -28.34 107.07 0.22 Allowed Pre-proline 0 C--N 1.303 -1.452 0 CA-C-N 113.34 -1.755 . . . . 7.0 112.589 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 52' ' ' SER . 15.9 Cg_endo -57.57 105.09 0.18 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.029 1.819 . . . . 6.71 109.819 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.446 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -108.09 147.61 30.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.81 -0.632 . . . . 4.33 112.023 -177.603 17.543 77.079 54.728 104.432 2.035 105.72 20.098 -123.981 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 54' ' ' CYS . 2.4 tt0 -24.92 137.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.214 -0.903 . . . . 4.93 111.606 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 m -124.91 178.71 5.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.075 -0.512 . . . . 4.68 110.042 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.447 ' O ' ' HE3' ' A' ' 59' ' ' LYS . . . -129.55 43.41 1.31 Allowed Glycine 0 CA--C 1.492 -1.403 0 C-N-CA 119.164 -1.493 . . . . 2.63 110.614 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.514 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 5.2 mm100 -96.7 82.51 3.31 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 113.156 0.799 . . . . 4.27 113.156 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.506 ' H ' ' HG2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -76.75 108.64 6.88 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 109.022 -0.733 . . . . 3.08 109.022 176.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.574 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 94.4 Cg_exo -39.78 156.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.11 2.54 . . . . 1.64 115.684 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -161.83 155.26 21.1 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.279 -1.328 . . . . 1.38 110.2 178.02 19.286 94.843 110.249 105.606 2.034 103.023 90.23 -167.815 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.24 6.89 12.63 Favored Glycine 0 N--CA 1.44 -1.093 0 CA-C-N 115.008 -0.996 . . . . 1.76 113.564 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.1 t -93.31 41.72 1.09 Allowed 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 117.386 0.593 . . . . 1.47 111.147 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.43 44.41 96.8 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.872 -0.604 . . . . 1.7 114.302 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.485 ' C ' ' HD3' ' A' ' 66' ' ' ARG . . . 157.52 -150.74 21.87 Favored Glycine 0 CA--C 1.502 -0.732 0 C-N-CA 120.864 -0.684 . . . . 1.45 114.33 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 5.3 mmt180 -122.34 155.46 35.95 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.185 -0.508 . . . . 2.77 110.151 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 17.6 t -63.31 160.14 16.51 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.346 -0.613 . . . . 1.17 109.346 178.541 -167.669 134.57 -135.554 104.103 2.032 102.625 -163.509 -103.311 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.686 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . -154.16 -99.23 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.798 -0.637 . . . . 1.25 112.265 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.828 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . -73.13 -169.92 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.624 1.17 . . . . 0.89 112.792 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.82 ' O ' ' HG3' ' A' ' 87' ' ' PRO . . . -39.31 75.59 0.0 OUTLIER 'General case' 0 C--N 1.366 1.29 0 N-CA-C 109.069 -0.715 . . . . 1.29 109.069 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.037 ' HA2' ' HB3' ' A' ' 85' ' ' CYS . . . 57.33 79.52 0.1 OUTLIER Glycine 0 N--CA 1.418 -2.531 0 C-N-CA 118.276 -1.916 . . . . 1.09 108.678 -175.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.697 HD13 ' C ' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -145.4 120.43 3.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.846 -0.798 . . . . 0.99 108.846 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.1 t -99.95 102.09 13.37 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 106.837 -1.542 . . . . 0.99 106.837 179.952 -167.815 90.23 110.249 103.023 2.034 105.606 94.843 19.286 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 2.1 t -88.93 153.95 20.62 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 113.424 0.898 . . . . 1.2 113.424 -175.777 -151.655 108.037 -75.627 103.919 2.028 104.69 -33.734 -45.0 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.483 ' HB3' ' CD ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -121.65 -179.16 0.7 Allowed Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 113.714 -1.585 . . . . 1.57 110.671 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' CD ' ' HB3' ' A' ' 75' ' ' SER . 11.7 Cg_exo -72.75 -10.57 25.14 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.857 2.371 . . . . 2.1 112.139 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.7 -32.33 7.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 2.67 111.256 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.87 170.07 38.22 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.804 -0.712 . . . . 1.62 112.756 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.632 ' HB3' ' CG2' ' A' ' 72' ' ' ILE . 10.4 m -98.56 162.36 13.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 112.099 0.407 . . . . 1.35 112.099 -179.932 -45.0 -33.734 -75.627 104.69 2.028 103.919 108.037 -151.655 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.697 ' C ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -152.45 145.82 24.8 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.726 -0.67 . . . . 1.89 109.93 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.475 ' N ' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -61.4 109.62 1.21 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 120.983 0.42 . . . . 2.38 111.437 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.779 ' OD1' ' C ' ' A' ' 71' ' ' GLY . 26.9 p-10 -91.08 118.01 68.26 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.806 -0.634 . . . . 2.18 111.459 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.575 ' HA ' ' N ' ' A' ' 89' ' ' ALA . 35.9 Cg_exo -61.56 -15.87 44.31 Favored 'Trans proline' 0 CA--C 1.509 -0.763 0 C-N-CA 124.786 3.657 . . . . 1.42 110.797 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.21 -12.53 59.63 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.481 -1.69 . . . . 1.26 112.776 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 1.037 ' HB3' ' HA2' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -123.88 -23.06 4.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 119.27 3.063 . . . . 1.25 119.27 -174.796 -103.311 -163.509 -135.554 102.625 2.032 104.103 134.57 -167.669 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.841 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 7.7 t70 167.2 -29.14 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.125 0 N-CA-C 119.55 3.167 . . . . 1.99 119.55 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.82 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 10.2 Cg_endo -102.09 -73.49 0.0 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.255 0 C-N-CA 123.447 2.765 . . . . 1.79 111.015 -175.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' OE1' ' HG3' ' A' ' 81' ' ' GLU . 5.1 tt0 -71.07 -6.46 39.28 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 113.72 -1.582 . . . . 2.4 106.997 176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.575 ' N ' ' HA ' ' A' ' 83' ' ' PRO . . . -76.76 -158.01 0.1 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 113.416 -1.72 . . . . 1.9 112.526 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 92' ' ' SER . . . -67.69 -173.18 0.31 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.818 -1.083 . . . . 2.09 108.536 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -73.08 62.03 0.62 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.96 -1.496 . . . . 4.82 106.96 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.473 ' CB ' ' HA ' ' A' ' 86' ' ' ASP . 1.8 t . . . . . 0 C--O 1.25 1.119 0 CA-C-N 114.46 -1.246 . . . . 2.71 111.15 -178.213 . . . . . . . . 1 1 . 1 stop_ save_